Literature DB >> 1957352

Molecular studies on trypanothione reductase, a target for antiparasitic drugs.

C Walsh1, M Bradley, K Nadeau.   

Abstract

Trypanosoma and Leishmania are parasitic protozoa that cause a variety of diseases, which include African sleeping sickness and oriental sore. Attempts to determine pharmaceutically exploitable differences between host and parasite biochemistry have identified the unique trypanothione pathway as a possible target. This pathway includes the enzyme trypanothione reductase, the parasite analogue of glutathione reductase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1957352     DOI: 10.1016/0968-0004(91)90124-e

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  4 in total

1.  Synthesis of symmetric disulfides as potential alternative substrates for trypanothione reductase and glutathione reductase: Part 1.

Authors:  R Jaouhari; T Besheya; J H McKie; K T Douglas
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

2.  Rational design of peptide-based inhibitors of trypanothione reductase as potential antitrypanosomal drugs.

Authors:  J Garforth; J H McKie; R Jaouhari; T J Benson; A H Fairlamb; K T Douglas
Journal:  Amino Acids       Date:  1994-10       Impact factor: 3.520

3.  Kukoamine A and other hydrophobic acylpolyamines: potent and selective inhibitors of Crithidia fasciculata trypanothione reductase.

Authors:  J A Ponasik; C Strickland; C Faerman; S Savvides; P A Karplus; B Ganem
Journal:  Biochem J       Date:  1995-10-15       Impact factor: 3.857

4.  In Silico Investigation of Flavonoids as Potential Trypanosomal Nucleoside Hydrolase Inhibitors.

Authors:  Christina Hung Hung Ha; Ayesha Fatima; Anand Gaurav
Journal:  Adv Bioinformatics       Date:  2015-11-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.